Menu

EMAP
Grup d’Estudis de Medicament en Atenció Primària (EMAP)

Group leader
40882722S - Rosa Morros Pedrós - OK retall
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Publications

Interacciones entre plantas medicinales y medicamentos en pacientes crónicos complejos en atención primaria.

Lázaro Romero E, Miranda Sánchez J, Zurilla Leonarte E, Vedia Urgell C, Massot Mesquida M, Serrano Serrano E, Solanellas Colomer L, Martínez Luque RM, Castillejo Medina JM, Merino Domínguez E, Seda Gombau G and Torán Monserrat P
Revista Espanola de Salud Publica. 2021 Aug 30; PMID:34459473

  • Year: 30/08/2021
  • FI: 1.333
  • Article

See more:
Primary health care research in COVID-19: analysis of the protocols reviewed by the ethics committee of IDIAPJGol, Catalonia

A. MOLERAS-SERRA, R. MORROS-PEDROS, M. MONTEAGUDO, C. VEDIA-URGELL and A. GOMEZ-LUMBRERAS
BMC Primary Care. 2023 Apr 6; . doi:10.1186/s12875-023-02025-5; PMID:37024845

See more:
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries

A. VELLINGA, A. LUKE-CURRIER, N. GARZON-ORJUELA, R. AABENHUS, M. ANASTASAKI, A. BALAN, F. BOHMER, V. LANG, S. CHLABICZ, S. COENEN, A. GARCIA-SANGENIS, A. KOWALCZYK, L. MALANIA, A. TOMACINSCHII, S. VAN DER LINDE, E. BONGARD, C. BUTLER, H. GOOSSENS and A. VAN DER VELDEN
Antibiotics-Basel. 2023 Mar 1; . doi:10.3390/antibiotics12030572; PMID:36978439

See more:
Implementation of a Centralized COVID-19 Vaccination Liaison Unit managed by Primary Care pharmacistpharmacologists

R. VALLES-FERNANDEZ, A. FRANZI-SISO, J. GARCIA-VICENTE, M. MASSOT-MESQUIDA, C. MORALES-NAVAJAS, E. PASTOR-RAMON, C. VEDIA-URGELL, B. DE ROBLES-BESNE, E. CID-GIMENEZ, G. MOLINA-FERNANDEZ, X. SEVILLA-MERINO, J. BONET-SIMO and W. PRAT-GIL
Pharmaceutical Care Espana. 2023 Jan 1;

See more:
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC(4)E trial in 15 European countries

X. LI, J. BILCKE, A. VAN DER VELDEN, R. BRUYNDONCKX, S. COENEN, E. BONGARD, M. DE PAOR, S. CHLABICZ, M. GODYCKI-CWIRKO, N. FRANCIS, R. AABENHUS, H. BUCHER, A. COLLIERS, A. DE SUTTER, A. GARCIA-SANGENIS, D. GLINZ, N. HARBIN, K. KOSIEK, M. LINDBAEK, C. LIONIS, C. LLOR, R. MIKO-PAUER, R. JURGUTE, B. SEIFERT, P. SUNDVALL, P. LUNDGREN, N. TSAKOUNTAKIS, T. VERHEIJ, H. GOOSSENS, C. BUTLER and P. BEUTELS
European Journal of Health Economics. 2022 Sep 22; . doi:10.1007/s10198-022-01521-2; PMID:36131214

See more:

Board of Trustees

Collaborators

Accreditations